KR102756155B1 - 도베실산을 포함하는 후안부 질환 치료를 위한 안과용 국소 조성물 - Google Patents

도베실산을 포함하는 후안부 질환 치료를 위한 안과용 국소 조성물 Download PDF

Info

Publication number
KR102756155B1
KR102756155B1 KR1020207018983A KR20207018983A KR102756155B1 KR 102756155 B1 KR102756155 B1 KR 102756155B1 KR 1020207018983 A KR1020207018983 A KR 1020207018983A KR 20207018983 A KR20207018983 A KR 20207018983A KR 102756155 B1 KR102756155 B1 KR 102756155B1
Authority
KR
South Korea
Prior art keywords
acid
dobesilicic
pharmaceutically acceptable
day
macular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020207018983A
Other languages
English (en)
Korean (ko)
Other versions
KR20200096569A (ko
Inventor
노르테스 자비에르 캅데빌라
아킬루에 하비에르 사나구스틴
가냔 마리아 이사벨 델가도
Original Assignee
라보라토리오스 에스에이엘브이에이티, 에스.에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 라보라토리오스 에스에이엘브이에이티, 에스.에이. filed Critical 라보라토리오스 에스에이엘브이에이티, 에스.에이.
Publication of KR20200096569A publication Critical patent/KR20200096569A/ko
Application granted granted Critical
Publication of KR102756155B1 publication Critical patent/KR102756155B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020207018983A 2017-12-04 2018-11-29 도베실산을 포함하는 후안부 질환 치료를 위한 안과용 국소 조성물 Active KR102756155B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17382832 2017-12-04
EP17382832.8 2017-12-04
PCT/EP2018/082999 WO2019110416A1 (en) 2017-12-04 2018-11-29 Ophthalmic topical composition comprising dobesilic acid for treating diseases of the posterior segment of the eye

Publications (2)

Publication Number Publication Date
KR20200096569A KR20200096569A (ko) 2020-08-12
KR102756155B1 true KR102756155B1 (ko) 2025-01-20

Family

ID=60673756

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020207018983A Active KR102756155B1 (ko) 2017-12-04 2018-11-29 도베실산을 포함하는 후안부 질환 치료를 위한 안과용 국소 조성물

Country Status (24)

Country Link
US (1) US20200390729A1 (enExample)
EP (1) EP3720428B1 (enExample)
JP (1) JP2021505554A (enExample)
KR (1) KR102756155B1 (enExample)
CN (1) CN111542316A (enExample)
AU (1) AU2018378981B2 (enExample)
BR (1) BR112020011160A2 (enExample)
CA (1) CA3083835A1 (enExample)
CL (1) CL2020001426A1 (enExample)
DK (1) DK3720428T3 (enExample)
ES (1) ES2941036T3 (enExample)
FI (1) FI3720428T3 (enExample)
HR (1) HRP20230319T1 (enExample)
HU (1) HUE061852T2 (enExample)
MA (1) MA50991B1 (enExample)
MX (1) MX2020005809A (enExample)
MY (1) MY205498A (enExample)
PH (1) PH12020550722A1 (enExample)
PL (1) PL3720428T3 (enExample)
PT (1) PT3720428T (enExample)
SG (1) SG11202004940VA (enExample)
SI (1) SI3720428T1 (enExample)
WO (1) WO2019110416A1 (enExample)
ZA (1) ZA202003944B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202300017430A1 (it) * 2023-08-22 2025-02-22 Service Biotech srl Soluzione oftalmica in forma di collirio contenente una isoforma umana ricombinante di manganese superossido dismutasi (rmnsod) per la cura di patologie dell’occhio
CN117257963B (zh) * 2023-11-02 2024-07-16 广州准优生物科技有限公司 含脐带间充质干细胞外泌体的眼用药剂及其制备方法和用途
CN117643573B (zh) * 2024-01-29 2024-05-03 天津医科大学眼科医院 一种可递送药物至眼后节的纳米滴眼液及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE51421B1 (en) * 1980-08-01 1986-12-24 Smith & Nephew Ass Ophthalmic compositions containing triamterene
US9198886B2 (en) * 2006-08-16 2015-12-01 Pedro Cuevas Sánchez Use of 2,5-dihydroxybenzene for the treatment of ocular diseases
CN104023736A (zh) * 2011-11-30 2014-09-03 埃克西金炎症有限公司 Jnk信号转导途径的细胞-可渗透肽抑制剂用于治疗干眼综合征的用途
ES2632012T3 (es) * 2012-02-02 2017-09-07 Invesfovea S.L. Uso del ácido 2,5-dihidroxibenceno sulfonato para el tratamiento de la degeneración macular relacionada con la edad
DK2822964T3 (en) * 2012-03-05 2018-12-10 Univ Wayne State IDENTIFICATION OF CHANNEL RHODOPSIN-2- (CHOP2) MUTATIONS AND METHODS OF USE
NZ700274A (en) * 2012-04-24 2016-10-28 Thrombogenics Nv Anti-pdgf-c antibodies
EP2875811A1 (en) * 2013-11-26 2015-05-27 Luis Antonio Outeirino Miguez Use of dobesilate for treating ocular haemorrhages

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
인도 특허공개 제03/2008호(1327/DEL/2006)

Also Published As

Publication number Publication date
CA3083835A1 (en) 2019-06-13
EP3720428A1 (en) 2020-10-14
MA50991A (fr) 2020-10-14
US20200390729A1 (en) 2020-12-17
HRP20230319T1 (hr) 2023-05-12
AU2018378981B2 (en) 2024-10-24
ES2941036T3 (es) 2023-05-16
PL3720428T3 (pl) 2023-05-08
CL2020001426A1 (es) 2020-11-06
PT3720428T (pt) 2023-04-03
PH12020550722A1 (en) 2021-02-15
CN111542316A (zh) 2020-08-14
SI3720428T1 (sl) 2023-05-31
KR20200096569A (ko) 2020-08-12
ZA202003944B (en) 2022-12-21
MY205498A (en) 2024-10-23
DK3720428T3 (da) 2023-03-20
WO2019110416A1 (en) 2019-06-13
MA50991B1 (fr) 2023-03-31
AU2018378981A1 (en) 2020-07-16
JP2021505554A (ja) 2021-02-18
EP3720428B1 (en) 2023-01-11
SG11202004940VA (en) 2020-06-29
FI3720428T3 (fi) 2023-03-30
MX2020005809A (es) 2020-08-20
BR112020011160A2 (pt) 2020-11-17
HUE061852T2 (hu) 2023-08-28

Similar Documents

Publication Publication Date Title
CN102340991B (zh) 向眼部递送受体酪氨酸激酶抑制性(RTKi)化合物的药物组合物
US20120101046A1 (en) Prophylactic or therapeutic agent for retinal disease and method for prophylaxis or therapy of retinal disease using jnk (c-jun amino-terminal kinase) - inhibitory peptide, and use of the peptide
EP3454858A1 (en) Combination treatment of ocular inflammatory disorders and diseases
KR102756155B1 (ko) 도베실산을 포함하는 후안부 질환 치료를 위한 안과용 국소 조성물
JPWO1999059634A1 (ja) 抗炎症点眼剤
CN101175487B (zh) 依布硒啉的制药用途
WO2016171152A1 (ja) 角膜障害の治療剤、改善剤または予防剤
US10973758B2 (en) Methods of eye treatment using therapeutic compositions containing dipyridamole
KR20140021505A (ko) 스쿠알라민 안약 제제
US20200171124A1 (en) Topical compositions for ophthalmic and otic use
US20250082602A1 (en) Ophthalmic composition containing recoflavone for the treatment of dry eye disease
KR20190050372A (ko) 압타머 및 항산화 물질의 복합체를 유효성분으로 포함하는 약학 조성물
US11045435B2 (en) Methods for treating ocular diseases
HK40036612B (en) Ophthalmic topical composition comprising dobesilic acid for treating diseases of the posterior segment of the eye
HK40036612A (en) Ophthalmic topical composition comprising dobesilic acid for treating diseases of the posterior segment of the eye
US12042500B2 (en) Mucoadhesive drug delivery system for ocular administration of fluoroquinolone antibiotics
US20220387422A1 (en) Ciprofloxacin ophthalmic topical composition for treating ocular disease
WO2025078308A1 (en) Gel formulation for topical ocular use
CN101432000A (zh) 用于变应性眼病或变应性鼻病的包含三环性三唑并苯并氮杂衍生物的预防剂或治疗剂
JP2741285B2 (ja) 緑内障治療剤
HK1166605A (en) Prophylactic or therapeutic agent for retinal diseases and method for preventing or treating retinal diseases, each comprising jnk (c-jun n-terminal kinase)-inhibiting peptide, and use of the peptide

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20200701

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20211129

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20231127

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20240726

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

AMND Amendment
PX0901 Re-examination

Patent event code: PX09012R01I

Patent event date: 20241022

Comment text: Amendment to Specification, etc.

PX0701 Decision of registration after re-examination

Patent event date: 20241029

Comment text: Decision to Grant Registration

Patent event code: PX07013S01D

X701 Decision to grant (after re-examination)
GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20250113

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20250114

End annual number: 3

Start annual number: 1

PG1601 Publication of registration